Tenax Therapeutics (TENX) Competitors $4.67 -0.10 (-2.10%) (As of 10:15 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends TENX vs. BASI, ALGS, MGX, INCR, CELU, CLRB, ATRA, CRVO, OPTN, and XFORShould you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include Bioanalytical Systems (BASI), Aligos Therapeutics (ALGS), Metagenomi (MGX), InterCure (INCR), Celularity (CELU), Cellectar Biosciences (CLRB), Atara Biotherapeutics (ATRA), CervoMed (CRVO), OptiNose (OPTN), and X4 Pharmaceuticals (XFOR). These companies are all part of the "medical" sector. Tenax Therapeutics vs. Bioanalytical Systems Aligos Therapeutics Metagenomi InterCure Celularity Cellectar Biosciences Atara Biotherapeutics CervoMed OptiNose X4 Pharmaceuticals Tenax Therapeutics (NASDAQ:TENX) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings. Do analysts rate TENX or BASI? Tenax Therapeutics presently has a consensus price target of $16.00, suggesting a potential upside of 232.64%. Given Tenax Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Tenax Therapeutics is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenax Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor TENX or BASI? Tenax Therapeutics received 16 more outperform votes than Bioanalytical Systems when rated by MarketBeat users. Likewise, 56.03% of users gave Tenax Therapeutics an outperform vote while only 38.55% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformTenax TherapeuticsOutperform Votes14456.03% Underperform Votes11343.97% Bioanalytical SystemsOutperform Votes12838.55% Underperform Votes20461.45% Do insiders & institutionals believe in TENX or BASI? 1.7% of Tenax Therapeutics shares are held by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are held by institutional investors. 3.7% of Tenax Therapeutics shares are held by company insiders. Comparatively, 11.5% of Bioanalytical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media favor TENX or BASI? In the previous week, Tenax Therapeutics had 18 more articles in the media than Bioanalytical Systems. MarketBeat recorded 18 mentions for Tenax Therapeutics and 0 mentions for Bioanalytical Systems. Tenax Therapeutics' average media sentiment score of 1.03 beat Bioanalytical Systems' score of 0.00 indicating that Tenax Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Tenax Therapeutics Positive Bioanalytical Systems Neutral Is TENX or BASI more profitable? Tenax Therapeutics has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. Bioanalytical Systems' return on equity of -42.74% beat Tenax Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tenax TherapeuticsN/A -46.00% -42.65% Bioanalytical Systems -7.75%-42.74%-6.38% Which has better earnings and valuation, TENX or BASI? Bioanalytical Systems has higher revenue and earnings than Tenax Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenax TherapeuticsN/AN/A-$7.71MN/AN/ABioanalytical Systems$60.47M0.59-$4.68M-$0.35-9.17 Which has more volatility and risk, TENX or BASI? Tenax Therapeutics has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. SummaryTenax Therapeutics beats Bioanalytical Systems on 10 of the 16 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENX vs. The Competition Export to ExcelMetricTenax TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.40M$6.48B$5.07B$8.80BDividend YieldN/A8.11%4.99%4.07%P/E RatioN/A4.9789.5613.60Price / SalesN/A371.451,224.8087.40Price / CashN/A52.5939.4536.27Price / Book0.1710.306.976.33Net Income-$7.71M$153.61M$119.04M$225.93M7 Day Performance-2.63%-1.73%-1.78%-0.96%1 Month Performance18.77%-7.26%-3.59%1.06%1 Year Performance-83.33%31.10%31.64%26.59% Tenax Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENXTenax Therapeutics2.7706 of 5 stars$4.67-2.1%$16.00+242.6%-83.5%$15.93MN/A0.009Analyst RevisionNews CoveragePositive NewsBASIBioanalytical SystemsN/A$3.21+15.1%N/A+22.9%$35.73M$60.47M-7.77397Analyst ForecastGap DownHigh Trading VolumeALGSAligos Therapeutics4.1561 of 5 stars$17.70-2.7%$75.00+323.7%+5.5%$63.54M$15.53M-1.3790MGXMetagenomi3.1701 of 5 stars$1.67+1.2%$15.50+828.1%N/A$62.49M$44.76M0.00236Analyst ForecastINCRInterCure1.2529 of 5 stars$1.36+2.0%N/A+16.0%$61.98M$96.61M0.00350Positive NewsCELUCelularity0.5369 of 5 stars$2.81-4.4%N/A+42.7%$61.79M$22.77M0.00220News CoverageCLRBCellectar Biosciences2.4949 of 5 stars$1.47-5.8%$20.00+1,260.5%-27.8%$60.67MN/A-0.9110Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageATRAAtara Biotherapeutics3.8253 of 5 stars$10.35-3.1%$16.67+61.0%-23.4%$59.62M$8.57M0.00165CRVOCervoMed1.3363 of 5 stars$9.56-0.8%$53.60+460.7%-1.8%$58.99M$7.14M0.004OPTNOptiNose3.9239 of 5 stars$0.39+5.1%$3.00+677.4%-69.2%$58.21M$70.99M-1.31190Gap UpXFORX4 Pharmaceuticals4.0062 of 5 stars$0.34-0.4%$2.88+748.1%-57.4%$57.82MN/A0.0080Analyst Revision Related Companies and Tools Related Companies Bioanalytical Systems Alternatives Aligos Therapeutics Alternatives Metagenomi Alternatives InterCure Alternatives Celularity Alternatives Cellectar Biosciences Alternatives Atara Biotherapeutics Alternatives CervoMed Alternatives OptiNose Alternatives X4 Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TENX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TENX Stock Alerts